Retrospective HER2 testing in gastric cancer biopsy specimens

被引：0
作者：
Bjelkenkrantz, K. [1 ]
Edsjo, A. [1 ]
机构：
[1] Lab Med Skane, Dept Pathol, Malmo, Sweden
来源：
VIRCHOWS ARCHIV | 2011年 / 459卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：S160 / S161
页数：2
相关论文
共 50 条
  • [41] Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens
    Ahn, Sangjeong
    Ahn, Soomin
    Van Vrancken, Michael
    Lee, Minju
    Ha, Sang Yun
    Lee, Hyuk
    Min, Byung-Hoon
    Lee, Jun Haeng
    Kim, Jae J.
    Choi, Sunkyu
    Jung, Sin-Ho
    Choi, Min Gew
    Lee, Jun-Ho
    Sohn, Tae Sung
    Bae, Jae Moon
    Kim, Sung
    Kim, Kyoung-Mee
    ONCOTARGET, 2015, 6 (35) : 38372 - 38380
  • [42] Testing for HER2 in breast cancer
    Lewis, F
    Jackson, P
    Lane, S
    Coast, G
    Hanby, AM
    HISTOPATHOLOGY, 2004, 45 (03) : 207 - 217
  • [43] HER2 status in paired of gastric biopsies and resection specimens: is biobsy reliable for prediction of HER2?
    Kara, M. E.
    Uzun, E.
    VIRCHOWS ARCHIV, 2019, 475 : S286 - S287
  • [44] Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma
    Hiroshi Yoshida
    Noriko Yamamoto
    Hirokazu Taniguchi
    Ichiro Oda
    Hitoshi Katai
    Ryoji Kushima
    Hitoshi Tsuda
    Virchows Archiv, 2014, 465 : 145 - 154
  • [45] Immunohistochemical determination of HER2 expression in breast cancer from core biopsy specimens: a reliable predictor of HEr2 status of the whole tumor
    Mueller-Holzner, E
    Fink, V
    Frede, T
    Marth, C
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (01) : 13 - 19
  • [46] Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma
    Yoshida, Hiroshi
    Yamamoto, Noriko
    Taniguchi, Hirokazu
    Oda, Ichiro
    Katai, Hitoshi
    Kushima, Ryoji
    Tsuda, Hitoshi
    VIRCHOWS ARCHIV, 2014, 465 (02) : 145 - 154
  • [47] Immunohistochemical determination of her2 expression in breast cancer from core biopsy specimens: a reliable predictor of her2 status of the whole tumor
    Elisabeth Mueller-Holzner
    Vroni Fink
    Thomas Frede
    Christian Marth
    Breast Cancer Research and Treatment, 2001, 69 : 13 - 19
  • [48] HER2 testing in gastric cancer. Results of ameeting of German experts
    Baretton, G.
    Dietel, M.
    Gaiser, T.
    Kirchner, T.
    Kreipe, H. H.
    Quaas, A.
    Roecken, C.
    Rueschoff, J.
    Tannapfel, A.
    Lordick, F.
    Al-Batran, S.
    Hofheinz, R.
    Lorenzen, S.
    Moehler, M.
    Thuss-Patience, P.
    PATHOLOGE, 2016, 37 (04): : 361 - 366
  • [49] Significance of accurate HER2 testing as a new biomarker in advanced gastric cancer
    Kusumoto, Tetsuya
    Ohtsu, Hajime
    Kawano, Hiroyuki
    Ando, Koji
    Ida, Satoshi
    Kimura, Yasuo
    Saeki, Hiroshi
    Oki, Eiji
    Morita, Masaru
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [50] How many biopsy fragments will be necessary to assess HER2 status for gastric cancer?
    Shinozaki, Eiji
    Yamamoto, Noriko
    Chin, Keisho
    Ogura, Mariko
    Suenaga, Mitsukuni
    Matsusaka, Satoshi
    Mizunuma, Nobuyuki
    Yamaguchi, Toshiharu
    Hatake, Kiyohiko
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345